Franklin Biotechnology Discovery Fund Class A (FBDIX)
| Fund Assets | 1.17B |
| Expense Ratio | 1.02% |
| Min. Investment | $1,000 |
| Turnover | 21.87% |
| Dividend (ttm) | 17.92 |
| Dividend Yield | 8.78% |
| Dividend Growth | 52.36% |
| Payout Frequency | n/a |
| Ex-Dividend Date | Dec 22, 2025 |
| Previous Close | 192.77 |
| YTD Return | 19.45% |
| 1-Year Return | 74.76% |
| 5-Year Return | 66.72% |
| 52-Week Low | 123.40 |
| 52-Week High | 205.13 |
| Beta (5Y) | 0.58 |
| Holdings | 111 |
| Inception Date | Sep 15, 1997 |
About FBDIX
Franklin Biotechnology Discovery Fund Class A is a mutual fund that seeks capital appreciation by investing at least 80% of its net assets in securities of biotechnology companies and discovery research firms. The fund focuses on companies involved in genomics, genetic engineering, gene therapy, pharmaceuticals, and related health care sectors. With a portfolio heavily weighted toward biotechnology and pharmaceutical industries, the fund aims to capitalize on innovations in cell and gene therapies, specialty drugs for rare diseases, and advanced treatment platforms. The fund maintains a diversified approach across approximately 80 biotechnology and pharmaceutical issuers, providing exposure to the evolving landscape of medical breakthroughs and therapeutic advancements. Managed by an experienced team since its inception, the fund distributes dividends annually and is designed for investors seeking long-term growth through participation in the biotechnology and life sciences sectors.
Performance
FBDIX had a total return of 74.76% in the past year, including dividends. Since the fund's inception, the average annual return has been 11.39%.
Top 10 Holdings
35.83% of assets| Name | Symbol | Weight |
|---|---|---|
| Jazz Pharmaceuticals plc | JAZZ | 5.65% |
| Amgen Inc. | AMGN | 4.25% |
| argenx SE | ARGX | 3.87% |
| Gilead Sciences, Inc. | GILD | 3.85% |
| Vertex Pharmaceuticals Incorporated | VRTX | 3.84% |
| Regeneron Pharmaceuticals, Inc. | REGN | 3.15% |
| Revolution Medicines, Inc. | RVMD | 3.10% |
| Ascendis Pharma A/S | ASND | 2.88% |
| Guardant Health, Inc. | GH | 2.66% |
| Oruka Therapeutics, Inc. | ORKA | 2.57% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 22, 2025 | $17.9181 | Dec 22, 2025 |
| Dec 20, 2024 | $11.7607 | Dec 20, 2024 |
| Dec 20, 2022 | $0.1411 | Dec 20, 2022 |
| Dec 15, 2021 | $17.6831 | Dec 15, 2021 |
| Dec 15, 2020 | $10.3921 | Dec 15, 2020 |
| Dec 16, 2019 | $14.1643 | Dec 18, 2019 |